Skip to main content
VIYASH SCIENTIFIC LIMITED logo

VIYASH SCIENTIFIC LIMITED — Investor Relations & Filings

Ticker · VIYASH ISIN · INE807F01027 LEI · 335800SXM7D3VSHF2X07 BSE.NS Manufacturing
Open in API
Filings indexed 1,409 across all filing types
Latest filing 2026-05-20 Report Publication Anno…
Country IN India
Listing BSE.NS VIYASH

About VIYASH SCIENTIFIC LIMITED

https://www.viyash.com

Viyash Scientific Limited is an integrated pharmaceutical platform specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and finished dosage forms. The organization operates a network of manufacturing facilities supported by robust research and development capabilities, focusing on complex chemistry and niche therapeutic segments. Its core business activities encompass the entire pharmaceutical value chain, from process development and scale-up to commercial-scale production. The company provides integrated solutions to global partners, leveraging its technical expertise in chemical synthesis and commitment to international quality standards. By maintaining a focus on operational excellence and innovation, the company serves as a strategic partner in the global healthcare supply chain, delivering high-quality medicinal components and formulations.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Report Publication Announcement Classification · 85% confidence The document is a notification to stock exchanges under SEBI listing regulations stating that the audio recording of the earnings call for the quarter/year ended March 31, 2026 is now available on the company’s website. It does not contain any financial data itself, nor is it the actual transcript or report—rather it announces the publication of the earnings‐call audio. This fits the definition of a Report Publication Announcement (RPA).
2026-05-20 English
Earnings call audio recording
Report Publication Announcement Classification · 90% confidence The document is a short announcement to stock exchanges stating that the audio recording of the earnings call (pertaining to audited financial results) has been made available on the company’s website. It does not contain any substantive financial data or the earnings content itself, but simply informs regulators of the publication of the recording. Under the “menu vs. meal” rule, this fits a Report Publication Announcement (RPA) rather than a financial report or earnings release.
2026-05-20 English
Copy of Newspaper Publication
Earnings Release Classification · 80% confidence The document is a formal submission under SEBI Listing Obligations (Regulation 30 & 47) providing “Extracts of Audited Standalone and Consolidated Financial Results” for the quarter and year ended March 31, 2026, as published in newspapers. It is not a full annual report (10-K), nor a meeting material, nor a certification only. It contains key highlights of periodical financial results and is effectively the company’s earnings release (initial announcement of quarterly and annual financial results). Therefore it best fits the Earnings Release category (ER). FY 2026
2026-05-20 English
Copy of Newspaper Publication -Audited Financial results
Earnings Release Classification · 85% confidence The document is a letter from Viyash Scientific Limited to the stock exchanges pursuant to SEBI LODR Regulations 30 & 47, enclosing copies of a newspaper advertisement that provides “Extracts of Audited Standalone and Consolidated Financial Results” for the quarter and year ended March 31, 2026. This is the public announcement of the company’s audited quarterly/annual results (key financial highlights), which corresponds to an Earnings Release rather than a full Annual or Interim Report or merely a publication notice. Therefore, the appropriate classification is ER (Earnings Release). FY 2026
2026-05-20 English
Investor Presentation
Investor Presentation Classification · 93% confidence The document is labeled and formatted as an ‘Investor Presentation for FY 2025-26’ in response to a SEBI Regulation 30 filing. It contains detailed slides on Q4/FY26 financial snapshots, performance highlights, business updates, merger synergy metrics, and forward-looking statements typical of a comprehensive investor deck rather than a simple earnings release or regulatory notice. Therefore, it matches the definition of an Investor Presentation (IP).
2026-05-19 English
Investor Presentation
Investor Presentation Classification · 94% confidence The document is labelled as "Investor Presentation for FY 2025-26" and contains slide‐style financial and strategic information (Q4/FY26 highlights, detailed consolidated P&L, business updates, merger synergies, etc.). It is a presentation deck provided under SEBI LODR Regulation 30, not merely an earnings snapshot and not the full statutory annual report. This matches the definition of an Investor Presentation (Code: IP).
2026-05-19 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.